Thursday, November 20, 2025 2:09:44 AM
He is not a shareholder. Very likely, just someone who gets paid to post using different IDs. No longs who have seriously held for about a decade or longer would be happy with the news. All the pumps that UK approval was going to bring a ton of non dilutive funding from big pharma and explosion in share price is quashed. The 3rd generation of bag holders will be wiped off in 2026/2027 too, guaranteed! Instead of recovering some of the losses folks will be losing even more money in the next year or two as dilution at increasingly lower share price accelerates throughout 2026 and 2027. The company will probably go under a $100M market cap (without NICE reimbursement) and at about 2.5B outstanding shares in 2027, you are potentially looking at under .04 share price in 2027, if not sooner.
The moves and posture also suggest that UK is likely going to reject the application. At the very least, you wont hear anything until end of Q1, 2026. That part is guaranteed!
LP ruins yet another Holiday season and destroys shareholder wealth yet again. Although LP’s financiers and shorts are going to have extended party! Easy money!
The moves and posture also suggest that UK is likely going to reject the application. At the very least, you wont hear anything until end of Q1, 2026. That part is guaranteed!
LP ruins yet another Holiday season and destroys shareholder wealth yet again. Although LP’s financiers and shorts are going to have extended party! Easy money!
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
